Ci

Circulation

Circulation represents the best in the field of cardiovascular medicine and science as well as basic science.

Looking to publish in Circulation? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Impact Factor 38.6
Quartile Q1
Open Access Type Hybrid
ISSN 0009-7322
eISSN 1524-4539
Invitation Only No
Cost Range Payment of page charges or an APC (article processing charge) may be required.

Submission Instructions

Circulation accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter Cover letter requirement is not specified.
Abstract A structured abstract (≤350 words) is required with headings: Background, Methods, Results, Conclusions.
Manuscript A Clinical Perspective section is required after the abstract: “What is new?” (2–3 bullets, max 100 words) and “What are the clinical implications?” (2–3 bullets, max 100 words), with each bullet a single complete sentence. Maximum length: ≤5,000 words.
References References use a numbered endnote style, cited in numerical order of first mention; list the first 10 authors then “et al.” Maximum number of references: 50.
Figures & Tables Tables must be provided as editable text (not images). Maximum number of figures and tables: 8.
Reformat to Circulation using Livewrite Premium

Research Letter

Cover Letter Cover letter requirement is not specified.
Abstract Abstract must not be included.
Manuscript Maximum length: 800 words. Section structure is specified: Title Page, Introduction, Methods, Results, Discussion, Acknowledgments, Sources of Funding, Disclosures, References.
References Maximum number of references: 5. References must use numbered endnotes and be cited in numerical order of first mention; list first 10 authors then “et al.”
Figures & Tables Only 1 figure or table is allowed. Figures/tables may be embedded in the main PDF; tables must be editable text (not images).
Reformat to Circulation using Livewrite Premium

Consensus Report

Cover Letter Cover letter requirement is not specified.
Abstract Unstructured abstract is required (200–350 words). References must not be cited in the abstract.
Manuscript Length ≤7,500 words (word count excludes title page, abstract, references, tables, and figure legends). Required order includes IMRaD sections plus “Non-standard Abbreviations and Acronyms” and a bulleted Clinical Perspective after the abstract.
References References are limited to ≤100. Numbered endnote style; cite in numerical order of first mention and list first 10 authors then “et al.”
Figures & Tables Maximum combined figures and tables: 8. Tables must be editable text (not images) and figures for publication must be TIFF/EPS/PDF (multi-panel figures assembled as one file).
Reformat to Circulation using Livewrite Premium

Commentary

Cover Letter Cover letter requirement is not specified. Cover-letter content requirements are not specified.
Abstract Abstract is required. Abstract word limit and structure/headings are not specified.
Manuscript Manuscript word/page/character limits are not specified. Manuscripts must be ordered: Title Page, Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, Sources of Funding, Disclosures, References, Tables, Figures with legends, plus a Clinical Perspective after the abstract.
References No maximum or minimum reference count is indicated. References must use numbered endnotes, cited in numerical order of first mention; list first 10 authors then “et al.”
Figures & Tables No maximum or minimum figure/table count is indicated. Tables must be editable text (not images) and included in the main manuscript; figure parts must be labeled and multi-paneled figures assembled into a single file.
Reformat to Circulation using Livewrite Premium

Recent Publications

Correction to: Development and Validation of the American Heart Association’s PREVENT Equations

Sadiya S. Khan, Kunihiro Matsushita, Yingying Sang, Shoshana H. Ballew, Morgan E. Grams, Aditya Surapaneni, Michael J. Blaha, April P. Carson, Alexander R. Chang, Elizabeth Ciemins, Alan S. Go, Orlando M. Gutierrez, Shih-Jen Hwang, Simerjot K. Jassal, Csaba P. Kovesdy, Donald M. Lloyd-Jones, Michael G. Shlipak, Latha P. Palaniappan, Laurence Sperling, Salim S. Virani, Katherine Tuttle, Ian J. Neeland, Sheryl L. Chow, Janani Rangaswami, Michael J. Pencina, Chiadi E. Ndumele, Josef Coresh

10.1161/cir.0000000000001491
View Publication

Approach to Heart Failure With Mildly Reduced Left Ventricular Ejection Fraction

Felix Lindberg, Lars H. Lund

10.1161/circulationaha.126.079813
View Publication

Prevalence, Predictors, and Clinical Implications of Residual Shunt After Patent Foramen Ovale Percutaneous Closure

Paul Guedeney, Julio I. Farjat-Pasos, Nicolas Meneveau, Claire Dauphin, Maik J. Grundeken, Jeremie Abtan, Meier Elbaz, Matthieu Besutti, Jules Mesnier, Lars S. Witte, Patrick Ohlmann, Gora Ndiaye, Marion Kibler, Marcel Am Beijk, Robbert J. de Winter, Gaetano Maria De Ferrari, Paolo Boretto, Romain Tresorier, Thibaut Pommier, Vincent Roule, Farzin Beygui, Nicolas Martin, Paul Gabrion, Hakim Benamer, Matthieu Perier, Vincent Auffret, Emmanuel Boiffard, Fabien Arabucki, Stéphanie Rouanet, Marie Dupuy, Florent Huang, Louis Giovachini, Michel Zeitouni, Nadjib Hammoudi, Johanne Silvain, Josep Rodés-Cabau, Gilles Montalescot, Niki Procopi, Anthony Elhadad, Perrine Devos, Thomas Wallet, Camille Granger, Eric Vicaut, Arthur Souquet, Alexis Hermida, Laurent Leborgne, Benjamain Haber, Paul Barsoum, Nadjib Lehbib, Marie Hauguel-Moreau, Gabriel Chevrot, Guillaume Cayla, Benoit Gerardin, Jean Noel Andarelli, Gregoire Albenque, Julien Rosencher, Sabrina Uhry, Camille Siegel, Laurent Payot, Farouk Abcha, Emmanuel Gall, Alexandre Lafont, Laszlo Levai, Anthony Matta, Philippe Garot, Gilles Rioufol, Jean-Michel Clerc, Radwane Hakim, Paul Luporsi, Chedi Yousfi, Fabien Huet, Pierre Aubry, Brahim Meftout

10.1161/circulationaha.126.081160
View Publication

Response by Munir et al to Letter Regarding Article, “CXCR6 + T Cells Drive Immune Checkpoint Inhibitor Myocarditis”

Amir Z. Munir, Paul Gougis, Javid J. Moslehi, Joe-Elie Salem

10.1161/circulationaha.126.081477
View Publication

Correction to: Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association

Daniel C. DeSimone, Laura Marks, Mark J. Dayer, Zerelda Esquer Garrigos, David Messika-Zeitoun, Patrick T. O’Gara, Gosta B. Pettersson, Emily M. Bucholz, Lindsey S. Andrews, Vance G. Fowler, Jose M. Miro, Larry M. Baddour

10.1161/cir.0000000000001485
View Publication

Frequently asked questions

How long does it take to publish?

Lead times for original research articles: submission to 1st decision 17 days; acceptance to publish ahead of print 7–10 days; acceptance to print publication 81 days.

Reformat to Circulation using Livewrite Premium

Is a cover letter required?

A cover letter is used to indicate changes to the author list in a revised submission.

Reformat to Circulation using Livewrite Premium

What are the publication costs?

Payment of page charges or an APC (article processing charge) may be required.

Reformat to Circulation using Livewrite Premium

Research Topics

Cardiac Imaging and Diagnostics Cardiovascular Function and Risk Factors Cardiovascular Health and Risk Factors Cardiac electrophysiology and arrhythmias Cardiac Arrhythmias and Treatments Cardiac Valve Diseases and Treatments Cardiovascular Disease and Adiposity Atrial Fibrillation Management and Outcomes Congenital Heart Disease Studies Cardiac pacing and defibrillation studies Cardiac Arrest and Resuscitation Coronary Interventions and Diagnostics Acute Myocardial Infarction Research Cardiac Structural Anomalies and Repair Cardiomyopathy and Myosin Studies Lipoproteins and Cardiovascular Health Heart Rate Variability and Autonomic Control Pulmonary Hypertension Research and Treatments Heart Failure Treatment and Management Cardiovascular Effects of Exercise Cardiac Ischemia and Reperfusion Mechanical Circulatory Support Devices Atherosclerosis and Cardiovascular Diseases Cerebrovascular and Carotid Artery Diseases Antiplatelet Therapy and Cardiovascular Diseases